A Neuropsychological Perspective on Attention Problems in Neurofibromatosis Type 1

被引：16

作者：

Templer, Alexandra K. ^{[1
]}

Titus, Jeffrey B. ^{[2
,3
]}

Gutmann, David H. ^{[1
]}

机构：

[1] Washington Univ, Sch Med, St Louis, MO USA

[2] Dell Childrens Med Ctr, 1301 Barbara Jordan Blvd,Suite 200, Austin, TX 78723 USA

[3] Univ Texas Austin, Austin, TX 78712 USA

来源：

JOURNAL OF ATTENTION DISORDERS | 2013年 / 17卷 / 06期

关键词：

neurofibromatosis; ADHD; cognitive functioning; NF1; ADD; DEFICIT HYPERACTIVITY DISORDER; UNIDENTIFIED BRIGHT OBJECTS; CORPUS-CALLOSUM MORPHOLOGY; DEFICIT/HYPERACTIVITY DISORDER; LEARNING-DISABILITIES; T2; HYPERINTENSITIES; COGNITIVE FUNCTION; MOUSE MODEL; CHILDREN; ADHD;

D O I：

10.1177/1087054711433422

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

Cognitive problems are common in children with neurofibromatosis type 1 and they can often complicate treatment. The current literature review examines cognitive functioning in neurofibromatosis type 1, with a specific focus on executive functioning. This includes exploration of how deficits in executive functioning are expressed in children with neurofibromatosis type 1 and how these deficits contrast with ADHD. The value of investigating subcomponents of executive functioning is discussed, as are implications for effective treatment and future research.

引用

页码：489 / 496

页数：8

共 50 条

[31] Neurofibromatosis type 1 comorbid with attention deficit and hyperactivity disorder. Case report
Calderon, P. Del Sol
Del Castillo, R. Paricio
Castano, L. Mallol
De la Puente, A. Izquierdo
Moreno, M. Garcia
EUROPEAN PSYCHIATRY, 2022, 65 : S431 - S431
[32] Psychometric Properties of Attention Measures in Young Children with Neurofibromatosis Type 1: Preliminary Findings
Pardej, Sara K.
Lee, Kristin M.
Glad, Danielle M.
Klein-Tasman, Bonita P.
JOURNAL OF PEDIATRIC NEUROPSYCHOLOGY, 2022, 8 (03) : 123 - 136
[33] Neurofibromatosis Type 1: Modeling CNS Dysfunction
Gutmann, David H.
Parada, Luis F.
Silva, Alcino J.
Ratner, Nancy
JOURNAL OF NEUROSCIENCE, 2012, 32 (41) : 14087 - 14093
[34] Evaluation of the basal ganglia in neurofibromatosis type 1
Nicita, Francesco
Di Biasi, Claudio
Sollaku, Saadi
Cecchini, Stefano
Salpietro, Vincenzo
Pittalis, Angelo
Papetti, Laura
Ursitti, Fabiana
Ulgiati, Fiorenza
Zicari, Anna Maria
Gualdi, Gian Franco
Properzi, Enrico
Duse, Marzia
Ruggieri, Martino
Spalice, Alberto
CHILDS NERVOUS SYSTEM, 2014, 30 (02) : 319 - 325
[35] Behavioural, academic and neuropsychological profile of normally gifted Neurofibromatosis type 1 children
Descheemaeker, MJ
Ghesquière, P
Symons, H
Fryns, JP
Legius, E
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH, 2005, 49 : 33 - 46
[36] Benefits of intervention in the Central Auditory Nervous System in individuals with Neurofibromatosis Type 1
Fontanelli, Raquel Caroline Ferreira Lopes
Aragao, Marcelo de Melo
Pinho, Ricardo Silva
Gil, Daniela
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2023, 172
[37] Treatment of Neurofibromatosis Type 1
Sabatini, Caterina
Milani, Donatella
Menni, Francesca
Tadini, Gianluca
Esposito, Susanna
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2015, 17 (06) : 1 - 11
[38] Attention Problems as a Predictor of Type 1 Diabetes Adherence and Metabolic Control Across Adolescence
Turner, Sara L.
Berg, Cynthia A.
Butner, Jonathan E.
Wiebe, Deborah J.
JOURNAL OF PEDIATRIC PSYCHOLOGY, 2018, 43 (01) : 72 - 82
[39] The adverse influence of attention-deficit disorder with or without hyperactivity on cognition in neurofibromatosis type 1
Lidzba, Karen
Granstroem, Sofia
Lindenau, Jorge
Mautner, Victor-Felix
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2012, 54 (10) : 892 - 897
[40] Using a Virtual Classroom environment to describe the attention deficits profile of children with Neurofibromatosis type 1
Gilboa, Yafit
Rosenblum, Sara
Fattal-Valevski, Aviva
Toledano-Alhadef, Hagit
Rizzo, Albert
Josman, Naomi
RESEARCH IN DEVELOPMENTAL DISABILITIES, 2011, 32 (06) : 2608 - 2613

← 1 2 3 4 5 →